In plasma EV, patients with PD had significantly higher pro-IL-1β (median: 1.37-fold increase after normalization by the control) and TGF-β1 (median: 1.22-fold increase after normalization by the control) levels than did the controls (Figure 1). This evidence concerns the gene IL1B and Parkinson disease.